| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 14.00B | 14.22B | 13.58B | 12.34B | 11.69B |
| Gross Profit | 10.12B | 10.62B | 10.07B | 9.21B | 8.78B |
| EBITDA | -4.79B | -6.66B | 1.40B | 17.98B | 9.15B |
| Net Income | -7.40B | -8.86B | -1.98B | 15.45B | 6.89B |
Balance Sheet | |||||
| Total Assets | 219.78B | 229.18B | 252.31B | 268.16B | 225.90B |
| Cash, Cash Equivalents and Short-Term Investments | 3.81B | 3.23B | 9.68B | 17.89B | 2.95B |
| Total Debt | 56.30B | 52.93B | 59.29B | 69.10B | 53.61B |
| Total Liabilities | 69.90B | 65.78B | 73.87B | 79.10B | 62.91B |
| Stockholders Equity | 150.10B | 163.47B | 178.82B | 188.94B | 162.69B |
Cash Flow | |||||
| Free Cash Flow | 6.78B | 8.94B | 8.40B | -11.17B | -3.20B |
| Operating Cash Flow | 6.82B | 9.01B | 8.48B | 6.27B | 5.84B |
| Investing Cash Flow | -1.91B | 1.52B | -509.00M | -24.69B | -10.70B |
| Financing Cash Flow | -4.65B | -14.36B | -14.71B | 29.85B | 5.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$156.16B | 14.39 | 2.75% | 4.33% | 27.01% | -20.16% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | HK$37.67B | 19.57 | 1.35% | 5.92% | -11.49% | -20.93% | |
61 Neutral | HK$17.48B | 56.17 | 1.20% | 5.77% | 1.06% | 799.41% | |
58 Neutral | HK$68.50B | -16.11 | -2.32% | 5.04% | -0.75% | -577.88% | |
55 Neutral | HK$94.66B | -12.69 | -4.80% | 7.61% | -3.07% | 17.04% | |
52 Neutral | HK$56.41B | 923.00 | 0.03% | 1.76% | -9.23% | ― |